Tuberculosis
"Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.
Descriptor ID |
D014376
|
MeSH Number(s) |
C01.252.410.040.552.846
|
Concept/Terms |
Tuberculosis- Tuberculosis
- Tuberculoses
- Kochs Disease
- Disease, Kochs
- Koch's Disease
- Disease, Koch's
- Koch Disease
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis".
- Tuberculosis
- Latent Tuberculosis
- Peritonitis, Tuberculous
- Tuberculoma
- Tuberculosis, Avian
- Tuberculosis, Bovine
- Tuberculosis, Cardiovascular
- Tuberculosis, Central Nervous System
- Tuberculosis, Cutaneous
- Tuberculosis, Endocrine
- Tuberculosis, Gastrointestinal
- Tuberculosis, Hepatic
- Tuberculosis, Laryngeal
- Tuberculosis, Lymph Node
- Tuberculosis, Miliary
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Ocular
- Tuberculosis, Oral
- Tuberculosis, Osteoarticular
- Tuberculosis, Pleural
- Tuberculosis, Pulmonary
- Tuberculosis, Splenic
- Tuberculosis, Urogenital
This graph shows the total number of publications written about "Tuberculosis" by people in UAMS Profiles by year, and whether "Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 2 | 1 | 3 | 2023 | 2 | 0 | 2 | 2022 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 | 2020 | 1 | 1 | 2 | 2019 | 4 | 0 | 4 | 2018 | 4 | 1 | 5 | 2017 | 3 | 0 | 3 | 2016 | 6 | 1 | 7 | 2015 | 4 | 3 | 7 | 2014 | 3 | 1 | 4 | 2013 | 1 | 0 | 1 | 2012 | 2 | 0 | 2 | 2011 | 4 | 1 | 5 | 2010 | 0 | 1 | 1 | 2009 | 5 | 1 | 6 | 2008 | 1 | 0 | 1 | 2007 | 4 | 1 | 5 | 2006 | 5 | 1 | 6 | 2005 | 4 | 0 | 4 | 2004 | 2 | 0 | 2 | 2003 | 3 | 0 | 3 | 2002 | 9 | 0 | 9 | 2001 | 4 | 1 | 5 | 2000 | 2 | 1 | 3 | 1999 | 3 | 1 | 4 | 1998 | 1 | 0 | 1 | 1997 | 5 | 1 | 6 | 1996 | 2 | 1 | 3 | 1995 | 1 | 0 | 1 | 1994 | 3 | 0 | 3 | 1993 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Tuberculosis" by people in Profiles over the past ten years.
-
Andrews JT, Zhang Z, Prasad GVRK, Huey F, Nazarova EV, Wang J, Ranaraja A, Weinkopff T, Li LX, Mu S, Birrer MJ, Huang SC, Zhang N, Arg?ello RJ, Philips JA, Mattila JT, Huang L. Metabolically active neutrophils represent a permissive niche for Mycobacterium tuberculosis. Mucosal Immunol. 2024 Oct; 17(5):825-842.
-
Panda S, Morgan J, Cheng C, Saito M, Gilman RH, Ciobanu N, Crudu V, Catanzaro DG, Catanzaro A, Rodwell T, Perera JSB, Chathuranga T, Gunasena B, DeSilva AD, Peters B, Sette A, Lindestam Arlehamn CS. Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection. Nat Commun. 2024 Jan 26; 15(1):765.
-
Humayun M, Mukasa L, Ye W, Bates JH, Yang Z. Racial and Ethnic Disparities in Tuberculosis Incidence, Arkansas, USA, 2010-2021. Emerg Infect Dis. 2024 Jan; 30(1):116-124.
-
Hanson EM, Seupaul R, Eastin C. Disseminated Tuberculosis with Cutaneous Findings in an Immunocompetent Patient: A Case Report. J Emerg Med. 2024 01; 66(1):e29-e32.
-
Pan SW, Catanzaro DG, Seifert M, Syed RR, Hillery N, Ho ML, Crudu V, Tudor E, Ciobanu N, Codreanu A, Catanzaro A, Rodwell TC. Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients. J Microbiol Immunol Infect. 2023 Oct; 56(5):1073-1083.
-
Kheirandish M, Catanzaro D, Crudu V, Zhang S. Integrating landmark modeling framework and machine learning algorithms for dynamic prediction of tuberculosis treatment outcomes. J Am Med Inform Assoc. 2022 04 13; 29(5):900-908.
-
Labuda SM, McDaniel CJ, Talwar A, Braumuller A, Parker S, McGaha S, Blissett C, Wortham JM, Mukasa L, Stewart RJ. Tuberculosis Outbreak Associated With Delayed Diagnosis and Long Infectious Periods in Rural Arkansas, 2010-2018. Public Health Rep. 2022 Jan-Feb; 137(1):94-101.
-
Pisu D, Huang L, Rin Lee BN, Grenier JK, Russell DG. Dual RNA-Sequencing of Mycobacterium tuberculosis-Infected Cells from a Murine Infection Model. STAR Protoc. 2020 12 18; 1(3):100123.
-
Garfein RS, Liu L, Cuevas-Mota J, Collins K, Catanzaro DG, Mu?oz F, Moser K, Chuck C, Higashi J, Bulterys MA, Raab F, Rios P. Evaluation of recorded video-observed therapy for anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2020 05 01; 24(5):520-525.
-
Blount RJ, Pascopella L, Barry P, Zabner J, Stapleton EM, Flood J, Balmes J, Nahid P, Catanzaro DG. Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California. Sci Total Environ. 2020 Apr 01; 711:134580.
-
Dooley KE, Hanna D, Mave V, Eisenach K, Savic RM. Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology. PLoS Med. 2019 07; 16(7):e1002842.
-
Huang L, Nazarova EV, Russell DG. Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage. Microbiol Spectr. 2019 03; 7(2).
-
Nazarova EV, Montague CR, Huang L, La T, Russell D, VanderVen BC. The genetic requirements of fatty acid import by Mycobacterium tuberculosis within macrophages. Elife. 2019 02 08; 8.
-
Gokulan K, Varughese KI. Drug resistance in Mycobacterium tuberculosis and targeting the l,d-transpeptidase enzyme. Drug Dev Res. 2019 02; 80(1):11-18.
-
Garfein RS, Liu L, Cuevas-Mota J, Collins K, Mu?oz F, Catanzaro DG, Moser K, Higashi J, Al-Samarrai T, Kriner P, Vaishampayan J, Cepeda J, Bulterys MA, Martin NK, Rios P, Raab F. Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis. 2018 10; 24(10):1806-1815.
-
Peloquin CA, Phillips PPJ, Mitnick CD, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Kaur P, Horsburgh CR. Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother. 2018 10; 62(10).
-
Xu Y, Wang L, Zimmerman MD, Chen KY, Huang L, Fu DJ, Kaya F, Rakhilin N, Nazarova EV, Bu P, Dartois V, Russell DG, Shen X. Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. PLoS Pathog. 2018 04; 14(4):e1006974.
-
Huang L, Nazarova EV, Tan S, Liu Y, Russell DG. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J Exp Med. 2018 04 02; 215(4):1135-1152.
-
Blount RJ, Pascopella L, Catanzaro DG, Barry PM, English PB, Segal MR, Flood J, Meltzer D, Jones B, Balmes J, Nahid P. Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California. Environ Health Perspect. 2017 09 29; 125(9):097026.
-
Huang L, Russell DG. Protective immunity against tuberculosis: what does it look like and how do we find it? Curr Opin Immunol. 2017 Oct; 48:44-50.
-
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017 Jan 15; 64(2):111-115.
-
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017 Jan 15; 64(2):e1-e33.
-
VanderVen BC, Huang L, Rohde KH, Russell DG. The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage. Microbiol Spectr. 2016 12; 4(6).
-
Stucki D, Brites D, Jeljeli L, Coscolla M, Liu Q, Trauner A, Fenner L, Rutaihwa L, Borrell S, Luo T, Gao Q, Kato-Maeda M, Ballif M, Egger M, Macedo R, Mardassi H, Moreno M, Tudo Vilanova G, Fyfe J, Globan M, Thomas J, Jamieson F, Guthrie JL, Asante-Poku A, Yeboah-Manu D, Wampande E, Ssengooba W, Joloba M, Henry Boom W, Basu I, Bower J, Saraiva M, Vaconcellos SEG, Suffys P, Koch A, Wilkinson R, Gail-Bekker L, Malla B, Ley SD, Beck HP, de Jong BC, Toit K, Sanchez-Padilla E, Bonnet M, Gil-Brusola A, Frank M, Penlap Beng VN, Eisenach K, Alani I, Wangui Ndung'u P, Revathi G, Gehre F, Akter S, Ntoumi F, Stewart-Isherwood L, Ntinginya NE, Rachow A, Hoelscher M, Cirillo DM, Skenders G, Hoffner S, Bakonyte D, Stakenas P, Diel R, Crudu V, Moldovan O, Al-Hajoj S, Otero L, Barletta F, Jane Carter E, Diero L, Supply P, Comas I, Niemann S, Gagneux S. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat Genet. 2016 12; 48(12):1535-1543.
-
Rothfeldt LL, Patil N, Haselow DT, Williams SH, Wheeler JG, Mukasa LN. Notes from the Field: Cluster of Tuberculosis Cases Among Marshallese Persons Residing in Arkansas - 2014-2015. MMWR Morb Mortal Wkly Rep. 2016 Aug 26; 65(33):882-3.
-
Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. J Subst Abuse Treat. 2017 01; 72:117-125.
-
Georghiou SB, Seifert M, Catanzaro D, Garfein RS, Valafar F, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. Antimicrob Agents Chemother. 2016 07; 60(7):3994-4004.
-
Cardenas VM, Orloff MS, Kaminaga J, Cardenas IC, Brown J, Hainline-Williams S, Duthie MS, Gonzalez-Puche AC, Mukasa L, Patil N, Mcelfish PA, Bates JH. Tuberculosis and leprosy infections in the Marshallese population of Arkansas, USA. Lepr Rev. 2016 Mar; 87(1):109-12.
-
Yamada S, Riklon S, Maskarinec GG. Ethical Responsibility for the Social Production of Tuberculosis. J Bioeth Inq. 2016 Mar; 13(1):57-64.
-
Wampande EM, Hatzios SK, Achan B, Mupere E, Nsereko M, Mayanja HK, Eisenach K, Boom WH, Gagneux S, Joloba ML. A single-nucleotide-polymorphism real-time PCR assay for genotyping of Mycobacterium tuberculosis complex in peri-urban Kampala. BMC Infect Dis. 2015 Sep 30; 15:396.
-
Torres JN, Paul LV, Rodwell TC, Victor TC, Amallraja AM, Elghraoui A, Goodmanson AP, Ramirez-Busby SM, Chawla A, Zadorozhny V, Streicher EM, Sirgel FA, Catanzaro D, Rodrigues C, Gler MT, Crudu V, Catanzaro A, Valafar F. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates. Emerg Microbes Infect. 2015 Jul; 4(7):e42.
-
Guzzetta G, Ajelli M, Yang Z, Mukasa LN, Patil N, Bates JH, Kirschner DE, Merler S. Effectiveness of contact investigations for tuberculosis control in Arkansas. J Theor Biol. 2015 Sep 07; 380:238-46.
-
Glaze LE, Rowe SL. Pharmacists' role in tuberculosis: Prevention, screening, and treatment. J Am Pharm Assoc (2003). 2015 Mar-Apr; 55(2):118, 120.
-
Deretic V, Kimura T, Timmins G, Moseley P, Chauhan S, Mandell M. Immunologic manifestations of autophagy. J Clin Invest. 2015 Jan; 125(1):75-84.
-
Birch SJ, Golbeck AL. The effectiveness of screening with interferon-gamma release assays in a university health care setting with a diverse global population. J Am Coll Health. 2015; 63(3):180-5.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|